Sort
21,453 grants matching “tuberculosis”
In Silico Screening for Cancer Targets
$138,509Marc Nicklaus · Division Of Basic Sciences - Nci · ZIC · FY2023 · CA
Bedside-to-Bench Research Training for Pediatric Infectious Diseases Fellows
$138,453Mark R. Schleiss · University Of Minnesota · T32 · FY2012 · HD
Animal Models Core
$138,376Myron E Hinsdale · Oklahoma State University Stillwater · P30 · FY2023 · GM
Clinical Predictors of weekly Rifapentine/isoniazid related adverse drug reactions during national roll-out of tuberculosis preventive therapy
$138,370Christine Sekaggya-Wiltshire · Infectious Diseases Institute · R01 · FY2021 · AI
Molecular epidemiology of drug-resistant tuberculosis in Peru
$138,357Mercedes C Becerra · Harvard Medical School · K01 · FY2008 · HL
Molecular Microbial Pathogenesis Training Program
$138,196Meharry Medical College · T32 · FY2005 · AI
Basic Science Core - Animal models
$138,129Shannan Hall-Ursone · Texas Biomedical Research Institute · P30 · FY2023 · AI
B cells and humoral immunity in tuberculosis
$138,096John R. Chan · Albert Einstein College Of Medicine, Inc · R01 · FY2015 · AI
Demographic Change and Dependent Social Structures
$138,041James Holland Jones · Stanford University · K01 · FY2009 · HD
Molecular Microbial Pathogenesis Training Program
$138,010Meharry Medical College · T32 · FY2004 · AI
Multidrug-resistant tuberculosis and HIV: Composition of Strains and biomarkers of treatment response
$137,943Patrick George Tobias Cudahy · Yale University · K01 · FY2023 · TW
Multidrug-resistant tuberculosis and HIV: Composition of Strains and biomarkers of treatment response
$137,917Patrick George Tobias Cudahy · Yale University · K01 · FY2022 · TW
Multidrug-resistant tuberculosis and HIV: Composition of Strains and biomarkers of treatment response
$137,917Patrick George Tobias Cudahy · Yale University · K01 · FY2023 · TW
DEVELOPMENT OF A M. TUBERCULOSIS DIAGNOSTIC KIT
$137,900Cellular Technology Limited · R43 · FY2000 · AI
Tulane Xavier Minority Training in International Health
$137,818Richard A Oberhelman · Tulane University Of Louisiana · T37 · FY2017 · MD
AREA: Elucidating cAMP signaling in Mycobacterium smegmatis
$137,800Michaela Anne Gazdik Stofer · Ferrum College · R15 · FY2009 · AI
Multidrug-resistant tuberculosis and HIV: Composition of Strains and biomarkers of treatment response
$137,797Patrick George Tobias Cudahy · Yale University · K01 · FY2021 · TW
CORE--Biosafety Core
$137,749Case Western Reserve University · P30 · FY2004 · AI
Clinical Predictors of weekly Rifapentine/isoniazid related adverse drug reactions during national roll-out of tuberculosis preventive therapy
$137,730Christine Sekaggya-Wiltshire · Infectious Diseases Institute · R01 · FY2023 · AI
UC Davis-China Infectious Disease Research Training
$137,719Kathryn Deriemer · University Of California At Davis · D43 · FY2010 · TW
Molecular epidemiology of drug-resistant tuberculosis in Peru
$137,635Mercedes C Becerra · Harvard Medical School · K01 · FY2007 · HL
Impact of antiretrovial therapy on liver fibrosis in Zambian HIV/HBV patients
$137,570Michael Jeffrey Vinikoor · University Of Alabama At Birmingham · K01 · FY2015 · TW
High-Throughput TB Vaccine Antigen Discovery
$137,515Amanda Martinot · Tufts University Boston · K08 · FY2022 · AI
Utilizing Single Cell Biological Approaches to Understand CNS TB
$137,453Chris G Dulla · Tufts University Boston · R21 · FY2020 · TW
Core A: Administrative Core
$137,441Joanne Turner · Texas Biomedical Research Institute · P01 · FY2020 · AG